{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:29:37Z","timestamp":1759336177634,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Approximately 70% of all hepatitis C (HCV) infections develop chronic disease. Active or exacerbated chronic hepatitis C infection subsequently progress to liver disease. The role of T-cells secretions in achieving viral clearance is still not well understood. Thus, the current study was set to determine the relationship between the T cell cytokine profiles, biochemical parameters and persistent HCV infection or spontaneous recovery.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty-five percent (41\/163) of the anti-HCV positive participants had recovered from HCV and had significantly higher concentration of IL-10 compared to those with active HCV infection (P\u2009&lt;\u20090.012). Other circulating cytokines measured; IL-2, IFN gamma, TNF alpha, IL-5 and IL-17 were similar in both groups. Participants with active HCV infection had significantly higher aspartate transaminase (AST) (35 units) and alanine transaminase (46 units) compared to those in the recovered state (P\u2009&lt;\u20090.001). Thus, serum levels of IL10 could be explored in larger prospective cohort study as a predictive marker of recovering from an active HCV infection.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13104-020-05313-w","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T17:02:43Z","timestamp":1602090163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased levels of circulating IL-10 in persons recovered from hepatitis C virus (HCV) infection compared with persons with active HCV infection"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-5870","authenticated-orcid":false,"given":"Dorcas Ohui","family":"Owusu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred Stephen","family":"Sarfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Frempong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"issue":"7","key":"5313_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.3184","volume":"19","author":"DL Thomas","year":"2013","unstructured":"Thomas DL. Global control of hepatitis C: Where challenge meets opportunity. Nat Med. 2013;19(7):850\u20138.","journal-title":"Nat Med"},{"key":"5313_CR2","unstructured":"WHO. Hepatitis C\u2014Fact Sheet. 2017. p. October."},{"issue":"10","key":"5313_CR3","first-page":"1","volume":"10","author":"AY Chen","year":"2015","unstructured":"Chen AY, Hoare M, Shankar AN, Allison M, Alexander GJM, Michalak TI, et al. Persistence of hepatitis C virus traces after spontaneous resolution of hepatitis C. PLoS ONE. 2015;10(10):1\u201316.","journal-title":"PLoS ONE"},{"key":"5313_CR4","doi-asserted-by":"crossref","unstructured":"Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Vol. 107, Blood. 2006. p. 892\u20137.","DOI":"10.1182\/blood-2005-07-2781"},{"key":"5313_CR5","doi-asserted-by":"crossref","unstructured":"Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005. 5(9):558\u201367. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16122679.","DOI":"10.1016\/S1473-3099(05)70216-4"},{"key":"5313_CR6","doi-asserted-by":"crossref","unstructured":"Arcjentini ARC, Kouruma F, Chionne P, Ucjo ED, Sabbatanp ESSDS, Rapicetta M. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol. 1996;77:2073\u20136.","DOI":"10.1099\/0022-1317-77-9-2073"},{"issue":"4","key":"5313_CR7","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/JCM.43.4.1902-1909.2005","volume":"43","author":"D Genovese","year":"2005","unstructured":"Genovese D, Dettori S, Argentini C, Villano U, Chionne P, Angelico M, et al. Molecular epidemiology of hepatitis C virus genotype 4 isolates in egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J Clin Microbiol. 2005;43(4):1902.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"5313_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<215::AID-JMV5>3.0.CO;2-K","volume":"58","author":"C Menendez","year":"1999","unstructured":"Menendez C, Sanchez-tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol. 1999;58(3):215\u201320.","journal-title":"J Med Virol"},{"issue":"2","key":"5313_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4269\/ajtmh.2005.73.460","volume":"73","author":"R Njouom","year":"2005","unstructured":"Njouom R, Pasquier C, Ayouba A, Tejiokem MC, Vessiere A, Mfoupouendoun J, et al. Low Risk of mother-to-child transmission of hepatitis C virus in Yaode, Cameroo: The ANRS 1262 Study. Am Soc Trop Med Hyg. 2005;73(2):460\u20136.","journal-title":"Am Soc Trop Med Hyg"},{"key":"5313_CR10","doi-asserted-by":"crossref","unstructured":"Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis [Internet]. 2012 Jul [cited 2013 Jun 10]; 55(Suppl 1):S10\u20135. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22715208.","DOI":"10.1093\/cid\/cis361"},{"issue":"5","key":"5313_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1099\/jmm.0.46414-0","volume":"55","author":"AA Adjei","year":"2006","unstructured":"Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Quaye IKE, Hesse IFA, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra Ghana. J Med Microbiol. 2006;55(5):593\u20137.","journal-title":"J Med Microbiol"},{"issue":"14","key":"5313_CR12","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.1128\/JVI.77.14.7914-7923.2003","volume":"77","author":"D Candotti","year":"2003","unstructured":"Candotti D, Temple J, Sarkodie F, Allain J. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana West Africa. J Virol. 2003;77(14):7914\u201323.","journal-title":"J Virol"},{"issue":"5","key":"5313_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1473-3099(02)00264-5","volume":"2","author":"V Madhava","year":"2002","unstructured":"Madhava V, Burgess C, Drucker E. Review Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002;2(5):293\u2013302.","journal-title":"Lancet Infect Dis"},{"issue":"9791","key":"5313_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2010","unstructured":"Nelson PK, Mathers BM, Cowie B, Hagan H, Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs : results of systematic reviews. Lancet. 2010;378(9791):571\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(11)61097-0.","journal-title":"Lancet"},{"issue":"3","key":"5313_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1046\/j.1423-0410.2001.00023.x","volume":"80","author":"F Sarkodie","year":"2001","unstructured":"Sarkodie F, Adarkwa M, Adu-Sarkodie Y, Candotti D, Acheampong JW, Allain JP. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang. 2001;80(3):142\u20137.","journal-title":"Vox Sang"},{"issue":"2","key":"5313_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1665-2681(19)31354-7","volume":"12","author":"MC Kew","year":"2013","unstructured":"Kew MC. Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol. 2013;12(2):173\u201382.","journal-title":"Ann Hepatol."},{"key":"5313_CR17","doi-asserted-by":"crossref","unstructured":"Petruzziello A. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. Open Virol J [Internet]. 2018. 12(Suppl-1, M3):26\u201332. http:\/\/benthamopen.com\/FULLTEXT\/TOVJ-12-26.","DOI":"10.2174\/1874357901812010026"},{"key":"5313_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MCG.0b013e3182872f29","volume":"47","author":"S Mittal","year":"2013","unstructured":"Mittal S, El-Serag HB. Epidemiology of HCC: Consider the Population. J Clin Gastroenterol. 2013;47:1\u201310.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"5313_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jcv.2007.07.005","volume":"40","author":"N Coppola","year":"2007","unstructured":"Coppola N, Pisapia R, Marrocco C, Martini S, Vatiero LM, Messina V, et al. Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol. 2007;40(2):110\u20135.","journal-title":"J Clin Virol"},{"issue":"3","key":"5313_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cyto.2003.10.005","volume":"25","author":"A Mangia","year":"2004","unstructured":"Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine. 2004;25(3):103\u20139.","journal-title":"Cytokine"},{"issue":"2","key":"5313_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MPG.0b013e31828febf0","volume":"57","author":"OG Shaker","year":"2013","unstructured":"Shaker OG, Nassar YH, Nour ZA, El Raziky M. Single-nucleotide polymorphisms of IL-10 and IL-28B as predictors of the response of IFN therapy in HCV genotype 4-infected children. J Pediatr Gastroenterol Nutr. 2013;57(2):155\u201360.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5313_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683\u2013765.","journal-title":"Annu Rev Immunol"},{"key":"5313_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71\u2013109.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"5313_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/jvh.12052","volume":"20","author":"WO Osburn","year":"2013","unstructured":"Osburn WO, Levine JS, Chattergoon MA, Thomas DL, Cox AL. Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection. J Viral Hepat. 2013;20(6):404\u201313.","journal-title":"J Viral Hepat"},{"key":"5313_CR25","doi-asserted-by":"crossref","unstructured":"Capobianco MP, Cassiano GC, Furini AA da C, Melo LMS de, Machado CRBD, Dantas RL, et al. Human Interleukin 2 (IL-2) Promotion of Immune Regulation and Clinical Outcomes: A Review. J Cytokine Biol. 2016. 1(109):14\u20137.","DOI":"10.4172\/2576-3881.1000109"},{"key":"5313_CR26","doi-asserted-by":"crossref","unstructured":"Schlaak JF, Schramm C, Radecke K, zum Buschenfelde K-HM, Gerken G. Sustained suppression of HCV replication and inflammatory activity after interleukin-2 therapy in patients with HIV\/hepatitis C virus coinfection. J Acquir Immune Defic Syndr. 2002. 29(2):145\u20138.","DOI":"10.1097\/00126334-200202010-00006"},{"issue":"1","key":"5313_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/biof.6","volume":"35","author":"V Fensterl","year":"2009","unstructured":"Fensterl V, Sen GC. Interferons and viral infections. BioFactors. 2009;35(1):14\u201320. https:\/\/doi.org\/10.1002\/biof.6.","journal-title":"BioFactors"},{"issue":"1","key":"5313_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/apm.12301","volume":"123","author":"AG Abdou","year":"2015","unstructured":"Abdou AG, Asaad NY, Ehsan N, Eltahmody M, El-Sabaawy MM, Elkholy S, et al. The role of IL-28, IFN-gamma, and TNF-alpha in predicting response to pegylated interferon\/ribavirin in chronic HCV patients. APMIS. 2015;123(1):18\u201327.","journal-title":"APMIS"},{"issue":"4","key":"5313_CR29","first-page":"251","volume":"21","author":"S Costantini","year":"2010","unstructured":"Costantini S, Capone F, Guerriero E, Maio P, Colonna G, Castello G. Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis. Eur Cytokine Netw. 2010;21(4):251\u20136.","journal-title":"Eur Cytokine Netw"},{"issue":"44","key":"5313_CR30","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.3748\/wjg.v19.i44.7867","volume":"19","author":"M Pompili","year":"2013","unstructured":"Pompili M, Biolato M, Miele L, Grieco A. Tumor necrosis factor-alpha inhibitors and chronic hepatitis C: a comprehensive literature review. World J Gastroenterol. 2013;19(44):7867\u201373.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"5313_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/jmv.22100","volume":"83","author":"JY Kim","year":"2011","unstructured":"Kim JY, Won JE, Jeong S-H, Park SJ, Hwang SG, Kang S-K, et al. Acute hepatitis C in Korea: different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion. J Med Virol. 2011;83(7):1195\u2013202.","journal-title":"J Med Virol"},{"key":"5313_CR32","doi-asserted-by":"crossref","unstructured":"Cho Y-K, Kim YN, Song B-C. Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection. Clin Mol Hepatol. 2014. 20(4):368\u201375. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4278068&tool=pmcentrez&rendertype=abstract.","DOI":"10.3350\/cmh.2014.20.4.368"},{"key":"5313_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugalcdep.2016.10.024","volume":"169","author":"JI Tsui","year":"2016","unstructured":"Tsui JI, Mirzazadeh A, Hahn JA, Maher L, Bruneau J, Grebely J, et al. The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. Drug Alcohol Depend. 2016;169:156\u201362.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"5313_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jhep.2016.04.030","volume":"65","author":"N Bulteel","year":"2016","unstructured":"Bulteel N, Partha Sarathy P, Forrest E, Stanley AJ, Innes H, Mills PR, et al. Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J Hepatol. 2016;65(2):266\u201372.","journal-title":"J Hepatol"},{"issue":"6","key":"5313_CR35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","volume":"6","author":"Hernandez and Sherman","year":"2011","unstructured":"Hernandez and Sherman. HIV\/HCV coinfection natural history and disease progression, a review of the most recent literature. Curr Opin HIV AIDS. 2011;6(6):478\u201382.","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"5313_CR36","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.3390\/ijms15069184","volume":"15","author":"CM Mastroianni","year":"2014","unstructured":"Mastroianni CM, Lichtner M, Mascia C, Zuccal\u00e0 P, Vullo V. Molecular mechanisms of liver fibrosis in HIV\/HCV coinfection. Int J Mol Sci. 2014;15(6):9184\u2013208.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5313_CR37","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.1840400419","volume":"40","author":"BA Piasecki","year":"2004","unstructured":"Piasecki BA, Lewis JD, Reddy KR, Bellamy SL, Porter SB, Weinrieb RM, et al. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology. 2004;40(4):892\u20139.","journal-title":"Hepatology"},{"issue":"6","key":"5313_CR38","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/hep.24308","volume":"53","author":"LH Nguyen","year":"2011","unstructured":"Nguyen LH, Ko S, Wong SS, Tran PS, Trinh HN, Garcia RT, et al. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. Hepatology. 2011;53(6):1839\u201345.","journal-title":"Hepatology"},{"key":"5313_CR39","doi-asserted-by":"crossref","unstructured":"Liu C-J. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues. J Gastroenterol Hepatol [Internet]. 2014. 29(1):26\u201330. http:\/\/doi.wiley.com\/10.1111\/jgh.12421.","DOI":"10.1111\/jgh.12421"},{"issue":"7","key":"5313_CR40","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3851\/IMP1842","volume":"16","author":"C-H Hung","year":"2011","unstructured":"Hung C-H, Lu S-N, Wang J-H, Hu T-H, Chen C-H, Huang C-M, et al. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients. Antivir Ther. 2011;16(7):959\u201368.","journal-title":"Antivir Ther"},{"issue":"7","key":"5313_CR41","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3851\/IMP1843","volume":"16","author":"JE Arends","year":"2011","unstructured":"Arends JE, van Assen S, Stek CJ, Wensing AM, Fransen JH, Schellens IM, et al. Pegylated interferon-alpha monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C. Antivir Ther. 2011;16(7):979\u201388.","journal-title":"Antivir Ther"},{"issue":"7 Pt 1","key":"5313_CR42","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1440-1746.2008.05489.x","volume":"23","author":"GV Matthews","year":"2008","unstructured":"Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol. 2008;23(7 Pt 1):1000\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"5313_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1530-0277.2008.00842.x","volume":"33","author":"G Szabo","year":"2009","unstructured":"Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res. 2009;33(2):220\u201332. https:\/\/doi.org\/10.1111\/j.1530-0277.2008.00842.x.","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"5313_CR44","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/cid\/ciu965","volume":"60","author":"JE Layden","year":"2015","unstructured":"Layden JE, Phillips RO, Owusu-Ofori S, Sarfo FS, Kliethermes S, Mora N, et al. High frequency of active HCV infection among seropositive cases in West Africa and evidence for multiple transmission pathways. Clin Infect Dis. 2015;60(7):1033\u201341.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-020-05313-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T03:08:57Z","timestamp":1633576137000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05313-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5313"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05313-w","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"26 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Research was performed in accordance with the Declaration of Helsinki. The study obtained written consent from all study participants. Research ethics approval was obtained from Kwame Nkrumah University of Science and Technology and the Komfo Anokye Teaching Hospital research ethics review committee before commencement (Reference; CHRPE\/AP\/134\/13, CHRPE\/AP\/443\/13 and CHRPE\/AP\/162\/15). Confidentiality of participants information was maintained at each level of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. There are no details relating to an individual person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests\u201d in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}